Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1838]
News [4199]
Articles [376]
Editorials [10]
Conferences [105]
elearning [29]
Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer
Tucatinib authorised by UK’s MHRA for locally advanced or metastatic HER2-positive breast cancer
Turbocharging the killing power of immune cells against cancer
Turbocharging the killing power of immune cells against cancer
Research reveals never-before-seen antibody binding and informing liver cancer and antibody design
Research reveals never-before-seen antibody binding and informing liver cancer and antibody design
Unexpected findings on weight loss and breast cancer from international study
Unexpected findings on weight loss and breast cancer from international study
SRC-3 is a novel regulator of human immune T regulatory cells
SRC-3 is a novel regulator of human immune T regulatory cells
European commission approves tucatinib for locally advanced/metastatic HER2 positive breast cancer
European commission approves tucatinib for locally advanced/metastatic HER2 positive breast cancer
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Intensity not paramount for physical training during cancer therapy
Intensity not paramount for physical training during cancer therapy
Popular breast cancer drugs don't work the way we thought they did
Popular breast cancer drugs don't work the way we thought they did
Drug is promising against pancreatic and breast cancers
Drug is promising against pancreatic and breast cancers

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation